- Home
- AXSM vs HASI Comparison
AXSM vs HASI Comparison
Compare AXSM & HASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- HASI
- Stock Information
- Founded
- AXSM 2012
- HASI 1981
- Country
- AXSM United States
- HASI United States
- Employees
- AXSM N/A
- HASI N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- HASI Real Estate Investment Trusts
- Sector
- AXSM Health Care
- HASI Real Estate
- Exchange
- AXSM Nasdaq
- HASI Nasdaq
- Market Cap
- AXSM 4.4B
- HASI 3.7B
- IPO Year
- AXSM 2015
- HASI 2013
- Fundamental
- Price
- AXSM $95.84
- HASI $34.63
- Analyst Decision
- AXSM Strong Buy
- HASI Buy
- Analyst Count
- AXSM 14
- HASI 11
- Target Price
- AXSM $124.57
- HASI $38.45
- AVG Volume (30 Days)
- AXSM 405.5K
- HASI 905.1K
- Earning Date
- AXSM 11-04-2024
- HASI 10-31-2024
- Dividend Yield
- AXSM N/A
- HASI 4.77%
- EPS Growth
- AXSM N/A
- HASI 292.73
- EPS
- AXSM N/A
- HASI 2.20
- Revenue
- AXSM $291,489,000.00
- HASI $154,509,000.00
- Revenue This Year
- AXSM $42.50
- HASI N/A
- Revenue Next Year
- AXSM $69.28
- HASI $4.02
- P/E Ratio
- AXSM N/A
- HASI $15.83
- Revenue Growth
- AXSM 59.73
- HASI 31.06
- 52 Week Low
- AXSM $55.02
- HASI $13.22
- 52 Week High
- AXSM $98.40
- HASI $36.15
- Technical
- Relative Strength Index (RSI)
- AXSM 64.19
- HASI 61.68
- Support Level
- AXSM $89.24
- HASI $34.22
- Resistance Level
- AXSM $96.71
- HASI $36.15
- Average True Range (ATR)
- AXSM 3.66
- HASI 1.01
- MACD
- AXSM 0.02
- HASI 0.16
- Stochastic Oscillator
- AXSM 87.05
- HASI 68.27
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About HASI Hannon Armstrong Sustainable Infrastructure Capital Inc.
Hannon Armstrong Sustainable Infrastructure Capital Inc provides debt and equity financing to the energy markets in the United States. The company focuses on investments in two types of projects: energy-efficiency projects and renewable-energy projects. Energy-efficiency projects reduce the energy use and energy cost of building or facility through the improvement or installation of building components including heat, ventilation, and air conditioning systems; lights; energy controls; roofs; windows; building shells; and heat and power systems. Renewable-energy projects deploy cleaner energy sources such as solar and wind to generate power production. The company also provides financing solutions for other projects to improve energy efficiency and the environment.